A Multi-Center, Randomized, Placebo-Controlled Clinical Trial Comparing Fesoterodine to Placebo in Women Diagnosed With Urge Urinary Incontinence by the 3 Incontinence Questions (3IQ). Followed by a Multi-Center Open Label Clinical Cohort Study of Long-Term Effects of Treatment With Fesoterodine.

Trial Profile

A Multi-Center, Randomized, Placebo-Controlled Clinical Trial Comparing Fesoterodine to Placebo in Women Diagnosed With Urge Urinary Incontinence by the 3 Incontinence Questions (3IQ). Followed by a Multi-Center Open Label Clinical Cohort Study of Long-Term Effects of Treatment With Fesoterodine.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Fesoterodine (Primary)
  • Indications Urge incontinence
  • Focus Therapeutic Use
  • Acronyms BRIDGES
  • Most Recent Events

    • 09 Dec 2015 Results of subgroup analysis published in the Journal of Urology
    • 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Aug 2011 Actual end date May 2011 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top